Professor Chris Day, Pro-Vice Chancellor of Medical Sciences and Professor of Liver Medicine at Newcastle University UK, has been elected as Vice-President (Clinical) of the Academy of Medical Sciences.

Professor Day has been head of the University’s medical faculty for seven years, where he has helped to build its world-renowned reputation in fields including ageing research, neuroscience, rheumatology, and his own subject – hepatology.
 
Professor Day’s work in hepatology has been influential in understanding genetic susceptibility to alcoholic and drug-induced liver disease. As a part of the renowned Liver Research Group, Professor Day has pioneered a new diagnostic technique to identify sufferers of non-alcoholic fatty liver disease, which could save the NHS £2 million a year. 
 
Professor Sir John Tooke, President, Academy of Medical Sciences said: “I am delighted that Professor Chris Day has been elected as the Academy’s next Vice President (Clinical). This is a key role engaging the Fellowship and working with the Honorary Officers to promote medical science and its translation into benefits for society. 
 
“Professor Day’s high academic standing and significant track record of achievement means he is well placed to lead and represent the Academy on matters related to clinical academic medicine.”
 
Honorary Officers of the Academy each serve a four-year term of office, their role being to provide strategic advice on all aspects of Academy business and procedures. Professor Day was elected to the Fellowship in 2008 and has previously served on the Academy’s Council between 2008 and 2011. 
 
Professor Day said: “I am delighted to have been elected the new Vice President (Clinical) by the Academy of Medical Sciences. This recognition reflects on the whole of Newcastle University and our commitment to carry out research that not only pushes out the boundaries of medicine, but also has an impact on society as a whole.” 
 
Professor Day is a member of the Medical Research Council’s governing body, Deputy Chair of the Medical Schools Council Executive Committee, a NIHR Senior Investigator and Chair of the Clinical Medicine Panel for the 2014 Research Excellence Framework (REF) - roles that have uniquely placed him to lead and represent the Academy on matters related to clinical academic medicine.  
 
Founded in 1998, the Academy of Medical Sciences (AMS) is the independent body in the UK that represents the diverse spectrum of medical science – from basic research through clinical application to healthcare delivery. Its mission is to promote medical science and its translation into benefits for society. 

published on: 1 July 2014